Assamese scientist Dr. Mukut Gohain co-invented and supported by Orchid Pharma of Chennai Chennai, India, have achieved a historic milestone as the United States Food and Drug Administration (USFDA) approved their novel antibiotic, ‘Enmetazobactam’.
This marks the first time an antibiotic completely developed in India has received FDA approval, after a painstaking 16-year journey from inception to market.
Dr. Gohain, a highly accomplished scientist with a Ph.D. from NEIST, India, and extensive international experience, is the Principal Investigator and Head of Research & Development at CPT.
Course Purchase Query 